{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:53:16Z","timestamp":1787003596260,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    To investigate the value of metagenomic next-generation sequencing (mNGS) in acute leukemia (AL) patients with febrile neutropenia (FN). We retrospectively reviewed 37 AL patients with FN and compared the results of mNGS with blood culture (BC) and the clinical features of the mNGS-positive group and the mNGS-negative group. A total of 14 detected pathogens were the final clinical diagnosis, of which 9 strains were detected only by mNGS and 5 strains were detected by both mNGS and BC. The top pathogens were\n                    <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                    ,\n                    <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                    and\n                    <jats:italic>Stenotrophomonas maltophilia<\/jats:italic>\n                    . A total of 67.57% (25\/37) were bacterial infections, and 2.7% (1\/37) were fungal or viral infections. The diagnostic positivity rate of mNGS (25\/37, 67.6%) was significantly higher than that of BC (7\/37, 18.9%), and the difference was statistically significant (p\u2009&lt;\u20090.05). Then, we explored the clinical distinction between the mNGS-positive group and the mNGS-negative group, and 3 features were filtered, including lymphocyte count (LY), creatinine levels (Cr), and white blood cell count (WBC). Our study demonstrated that early implementation of mNGS can effectively improve the efficacy of pathogen detection in AL patients with FN. The higher diagnostic positivity rate and the ability to detect additional pathogens compared to BC made mNGS a valuable tool in the management of infectious complications in this patient population. Furthermore, the identified clinical features associated with mNGS results provided additional insights for the clinical indication of infection in AL patients with FN.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-47685-6","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T14:03:52Z","timestamp":1700489032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Blood plasma metagenomic next-generation sequencing for identifying pathogens of febrile neutropenia in acute leukemia patients"],"prefix":"10.1038","volume":"13","author":[{"given":"Yan","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-Qiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Song","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,20]]},"reference":[{"key":"47685_CR1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/diagnostics12081800","volume":"12","author":"E Boeriu","year":"2022","unstructured":"Boeriu, E. et al. Diagnosis and management of febrile neutropenia in pediatric oncology patients-a systematic review. Diagn. (Basel) 12, 142. https:\/\/doi.org\/10.3390\/diagnostics12081800 (2022).","journal-title":"Diagn. (Basel)"},{"issue":"Suppl 2","key":"47685_CR2","first-page":"55","volume":"32","author":"F Escrihuela-Vidal","year":"2019","unstructured":"Escrihuela-Vidal, F., Laporte, J., Albasanz-Puig, A. & Gudiol, C. Update on the management of febrile neutropenia in hematologic patients. Rev. Esp. Quimioter. 32(Suppl 2), 55\u201358 (2019).","journal-title":"Rev. Esp. Quimioter."},{"key":"47685_CR3","doi-asserted-by":"publisher","first-page":"e2021025","DOI":"10.4084\/MJHID.2021.025","volume":"13","author":"M Nucci","year":"2021","unstructured":"Nucci, M. How I treat febrile neutropenia. Mediterr. J. Hematol. Infect. Dis. 13, e2021025. https:\/\/doi.org\/10.4084\/MJHID.2021.025 (2021).","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"47685_CR4","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1093\/cid\/ciab324","volume":"74","author":"E Benamu","year":"2022","unstructured":"Benamu, E. et al. Plasma microbial cell-free DNA Next-generation sequencing in the diagnosis and management of febrile neutropenia. Clin. Infect. Dis. 74, 1659\u20131668. https:\/\/doi.org\/10.1093\/cid\/ciab324 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"47685_CR5","doi-asserted-by":"publisher","first-page":"101548","DOI":"10.1016\/j.bjid.2021.101548","volume":"25","author":"M Garnica","year":"2021","unstructured":"Garnica, M., Pierrotti, L. C., Oliveira, P. V., Mazzi, M. & Chebabo, A. Metagenomic next-generation sequencing (mNGS) for diagnostically challenging infectious diseases in patients with acute leukemia. Braz. J. Infect. Dis. 25, 101548. https:\/\/doi.org\/10.1016\/j.bjid.2021.101548 (2021).","journal-title":"Braz. J. Infect. Dis."},{"key":"47685_CR6","doi-asserted-by":"publisher","first-page":"896","DOI":"10.20892\/j.issn.2095-3941.2020.0069","volume":"17","author":"Y Ba","year":"2020","unstructured":"Ba, Y. et al. Current management of chemotherapy-induced neutropenia in adults: Key points and new challenges: Committee of Neoplastic Supportive-Care (CONS), China Anti-Cancer Association Committee of Clinical Chemotherapy, China Anti-Cancer Association. Cancer Biol. Med. 17, 896\u2013909. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2020.0069 (2020).","journal-title":"Cancer Biol. Med."},{"key":"47685_CR7","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1200\/GO.20.00578","volume":"7","author":"ML Gonzalez","year":"2021","unstructured":"Gonzalez, M. L. et al. The golden hour: Sustainability and clinical outcomes of adequate time to antibiotic administration in children with cancer and febrile neutropenia in Northwestern Mexico. JCO Glob. Oncol. 7, 659\u2013670. https:\/\/doi.org\/10.1200\/GO.20.00578 (2021).","journal-title":"JCO Glob. Oncol."},{"key":"47685_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41576-019-0113-7","volume":"20","author":"CY Chiu","year":"2019","unstructured":"Chiu, C. Y. & Miller, S. A. Clinical metagenomics. Nat. Rev. Genet. 20, 341\u2013355. https:\/\/doi.org\/10.1038\/s41576-019-0113-7 (2019).","journal-title":"Nat. Rev. Genet."},{"key":"47685_CR9","doi-asserted-by":"publisher","first-page":"1186424","DOI":"10.3389\/fmicb.2023.1186424","volume":"14","author":"M Batool","year":"2023","unstructured":"Batool, M. & Galloway-Pena, J. Clinical metagenomics-challenges and future prospects. Front. Microbiol. 14, 1186424. https:\/\/doi.org\/10.3389\/fmicb.2023.1186424 (2023).","journal-title":"Front. Microbiol."},{"key":"47685_CR10","doi-asserted-by":"publisher","first-page":"1023978","DOI":"10.3389\/fcimb.2022.1023978","volume":"12","author":"Y Pan","year":"2022","unstructured":"Pan, Y. et al. Cellular analysis and metagenomic next-generation sequencing of bronchoalveolar lavage fluid in the distinction between pulmonary non-infectious and infectious disease. Front. Cell Infect. Microbiol. 12, 1023978. https:\/\/doi.org\/10.3389\/fcimb.2022.1023978 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"47685_CR11","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1093\/clinchem\/hvaa183","volume":"66","author":"LM Filkins","year":"2020","unstructured":"Filkins, L. M., Bryson, A. L., Miller, S. A. & Mitchell, S. L. Navigating clinical utilization of direct-from-specimen metagenomic pathogen detection: Clinical applications, limitations, and testing recommendations. Clin. Chem. 66, 1381\u20131395. https:\/\/doi.org\/10.1093\/clinchem\/hvaa183 (2020).","journal-title":"Clin. Chem."},{"key":"47685_CR12","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2147\/IDR.S396699","volume":"16","author":"L Zheng","year":"2023","unstructured":"Zheng, L. et al. Evaluation of the diagnostic performance of mNGS in detecting intra-abdominal infections of the emergency department patients. Infect. Drug Resist. 16, 1421\u20131432. https:\/\/doi.org\/10.2147\/IDR.S396699 (2023).","journal-title":"Infect. Drug Resist."},{"key":"47685_CR13","doi-asserted-by":"publisher","first-page":"1117987","DOI":"10.3389\/fcimb.2023.1117987","volume":"13","author":"C Qin","year":"2023","unstructured":"Qin, C. et al. Diagnostic value of metagenomic next-generation sequencing in sepsis and bloodstream infection. Front. Cell Infect. Microbiol. 13, 1117987. https:\/\/doi.org\/10.3389\/fcimb.2023.1117987 (2023).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"47685_CR14","doi-asserted-by":"publisher","first-page":"101910","DOI":"10.1016\/j.legalmed.2021.101910","volume":"52","author":"Z Yu","year":"2021","unstructured":"Yu, Z. et al. NGS plus bacterial culture: A more accurate method for diagnosing forensic-related nosocomial infections. Leg Med. (Tokyo) 52, 101910. https:\/\/doi.org\/10.1016\/j.legalmed.2021.101910 (2021).","journal-title":"Leg Med. (Tokyo)"},{"key":"47685_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2021.09.015","author":"WC Liao","year":"2021","unstructured":"Liao, W. C. et al. Changing epidemiology and prognosis of nosocomial bloodstream infection: A single-center retrospective study in Taiwan. J. Microbiol. Immunol. Infect. https:\/\/doi.org\/10.1016\/j.jmii.2021.09.015 (2021).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"47685_CR16","doi-asserted-by":"publisher","first-page":"ofw144","DOI":"10.1093\/ofid\/ofw144","volume":"3","author":"MK Abril","year":"2016","unstructured":"Abril, M. K. et al. Diagnosis of capnocytophaga canimorsus sepsis by whole-genome next-generation sequencing. Open Forum Infect. Dis. 3, ofw144. https:\/\/doi.org\/10.1093\/ofid\/ofw144 (2016).","journal-title":"Open Forum Infect. Dis."},{"key":"47685_CR17","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41564-018-0349-6","volume":"4","author":"TA Blauwkamp","year":"2019","unstructured":"Blauwkamp, T. A. et al. Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease. Nat. Microbiol. 4, 663\u2013674. https:\/\/doi.org\/10.1038\/s41564-018-0349-6 (2019).","journal-title":"Nat. Microbiol."},{"key":"47685_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13073-016-0326-8","volume":"8","author":"S Grumaz","year":"2016","unstructured":"Grumaz, S. et al. Next-generation sequencing diagnostics of bacteremia in septic patients. Genome Med. 8, 73. https:\/\/doi.org\/10.1186\/s13073-016-0326-8 (2016).","journal-title":"Genome Med."},{"key":"47685_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41591-020-1105-z","volume":"27","author":"W Gu","year":"2021","unstructured":"Gu, W. et al. Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids. Nat. Med. 27, 115\u2013124. https:\/\/doi.org\/10.1038\/s41591-020-1105-z (2021).","journal-title":"Nat. Med."},{"key":"47685_CR20","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1200\/JCO.19.01916","volume":"38","author":"Y Kanda","year":"2020","unstructured":"Kanda, Y. et al. D-index-guided early antifungal therapy versus empiric antifungal therapy for persistent febrile neutropenia: A randomized controlled noninferiority trial. J. Clin. Oncol. 38, 815\u2013822. https:\/\/doi.org\/10.1200\/JCO.19.01916 (2020).","journal-title":"J. Clin. Oncol."},{"key":"47685_CR21","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s40121-020-00353-y","volume":"9","author":"X Wu","year":"2020","unstructured":"Wu, X. et al. Etiology of severe community-acquired pneumonia in adults based on metagenomic next-generation sequencing: A prospective multicenter study. Infect. Dis. Ther. 9, 1003\u20131015. https:\/\/doi.org\/10.1007\/s40121-020-00353-y (2020).","journal-title":"Infect. Dis. Ther."},{"key":"47685_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/ice.2019.296","volume":"41","author":"LM Weiner-Lastinger","year":"2020","unstructured":"Weiner-Lastinger, L. M. et al. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015\u20132017. Infect. Control Hosp. Epidemiol. 41, 1\u201318. https:\/\/doi.org\/10.1017\/ice.2019.296 (2020).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"47685_CR23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1128\/CMR.00002-14","volume":"27","author":"KB Laupland","year":"2014","unstructured":"Laupland, K. B. & Church, D. L. Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin. Microbiol. Rev. 27, 647\u2013664. https:\/\/doi.org\/10.1128\/CMR.00002-14 (2014).","journal-title":"Clin. Microbiol. Rev."},{"key":"47685_CR24","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/jac\/dkq088","volume":"65","author":"A Corona","year":"2010","unstructured":"Corona, A., Bertolini, G., Lipman, J., Wilson, A. P. & Singer, M. Antibiotic use and impact on outcome from bacteraemic critical illness: The BActeraemia Study in Intensive Care (BASIC). J. Antimicrob. Chemother. 65, 1276\u20131285. https:\/\/doi.org\/10.1093\/jac\/dkq088 (2010).","journal-title":"J. Antimicrob. Chemother."},{"key":"47685_CR25","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00134-020-05950-6","volume":"46","author":"JF Timsit","year":"2020","unstructured":"Timsit, J. F., Ruppe, E., Barbier, F., Tabah, A. & Bassetti, M. Bloodstream infections in critically ill patients: An expert statement. Intensive Care Med. 46, 266\u2013284. https:\/\/doi.org\/10.1007\/s00134-020-05950-6 (2020).","journal-title":"Intensive Care Med."},{"key":"47685_CR26","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.eimc.2014.02.006","volume":"32","author":"R Zaragoza","year":"2014","unstructured":"Zaragoza, R., Ramirez, P. & Lopez-Pueyo, M. J. Nosocomial infections in intensive care units. Enferm. Infecc. Microbiol. Clin. 32, 320\u2013327. https:\/\/doi.org\/10.1016\/j.eimc.2014.02.006 (2014).","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"47685_CR27","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJMoa1405870","volume":"372","author":"S Jain","year":"2015","unstructured":"Jain, S. et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N. Engl. J. Med. 372, 835\u2013845. https:\/\/doi.org\/10.1056\/NEJMoa1405870 (2015).","journal-title":"N. Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47685-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47685-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47685-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T14:39:17Z","timestamp":1700491157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47685-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,20]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["47685"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-47685-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,20]]},"assertion":[{"value":"30 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20297"}}